Literature DB >> 21767156

Skin and soft tissue infections: the new surgical infection society guidelines.

Addison K May1.   

Abstract

BACKGROUND: The Surgical Infection Society Guidelines for the treatment of complicated skin and soft tissue infections (SSTIs) were published in October 2009 in Surgical Infections, and an overview of these guidelines was provided at the Thirtieth Annual Meeting of the Society. A summary of this overview is provided.
METHODS: Review of relevant papers related to complicated SSTIs published between 1966 and 2008 with graded recommendations and summations of general epidemiology and recommendations.
RESULTS: The frequency of SSTI has increased over the past decade, predominately because of an increase in infections caused by community-acquired methicillin-resistant Staphylococcus aureus. Drug resistance is increasing among all pathogens. A total of 61 graded recommendations were made in the complete guidelines, 28 of which are presented here, separated into those for non-necrotizing and necrotizing infections.
CONCLUSIONS: Appropriate antibiotic therapy should be provided in complicated SSTIs. Early diagnosis and treatment of necrotizing infections is paramount, as time to therapy alters morbidity and mortality rates.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21767156     DOI: 10.1089/sur.2011.034

Source DB:  PubMed          Journal:  Surg Infect (Larchmt)        ISSN: 1096-2964            Impact factor:   2.150


  7 in total

Review 1.  Management of acute bacterial skin and skin structure infections with a focus on patients at high risk of treatment failure.

Authors:  Abraham Pulido-Cejudo; Mario Guzmán-Gutierrez; Abel Jalife-Montaño; Alejandro Ortiz-Covarrubias; Jose Luis Martínez-Ordaz; Héctor Faustino Noyola-Villalobos; Luis Mauricio Hurtado-López
Journal:  Ther Adv Infect Dis       Date:  2017-08-31

Review 2.  Community-associated methicillin-resistant Staphylococcus aureus infection: Literature review and clinical update.

Authors:  Kassandra Loewen; Yoko Schreiber; Mike Kirlew; Natalie Bocking; Len Kelly
Journal:  Can Fam Physician       Date:  2017-07       Impact factor: 3.275

3.  Analysis of host-pathogen gene association networks reveals patient-specific response to streptococcal and polymicrobial necrotising soft tissue infections.

Authors:  Sanjeevan Jahagirdar; Lorna Morris; Nirupama Benis; Oddvar Oppegaard; Mattias Svenson; Ole Hyldegaard; Steinar Skrede; Anna Norrby-Teglund; Vitor A P Martins Dos Santos; Edoardo Saccenti
Journal:  BMC Med       Date:  2022-05-04       Impact factor: 11.150

4.  Impact of Intravenous Immunoglobulin on Survival in Necrotizing Fasciitis With Vasopressor-Dependent Shock: A Propensity Score-Matched Analysis From 130 US Hospitals.

Authors:  Sameer S Kadri; Bruce J Swihart; Stephanie L Bonne; Samuel F Hohmann; Laura V Hennessy; Peter Louras; Heather L Evans; Chanu Rhee; Anthony F Suffredini; David C Hooper; Dean A Follmann; Eileen M Bulger; Robert L Danner
Journal:  Clin Infect Dis       Date:  2017-04-01       Impact factor: 9.079

Review 5.  Management of complicated skin and soft tissue infections with a special focus on the role of newer antibiotics.

Authors:  Hoe Nam Leong; Asok Kurup; Mak Yong Tan; Andrea Lay Hoon Kwa; Kui Hin Liau; Mark H Wilcox
Journal:  Infect Drug Resist       Date:  2018-10-25       Impact factor: 4.003

6.  Wound Infections of Snakebites from the Venomous Protobothrops mucrosquamatus and Viridovipera stejnegeri in Taiwan: Bacteriology, Antibiotic Susceptibility, and Predicting the Need for Antibiotics-A BITE Study.

Authors:  Chih-Chuan Lin; Yen-Chia Chen; Zhong Ning Leonard Goh; Chen-Ken Seak; Joanna Chen-Yeen Seak; Gao Shi-Ying; Chen-June Seak
Journal:  Toxins (Basel)       Date:  2020-09-07       Impact factor: 4.546

7.  Wound Infections from Taiwan Cobra (Naja atra) Bites: Determining Bacteriology, Antibiotic Susceptibility, and the Use of Antibiotics-A Cobra BITE Study.

Authors:  Heng Yeh; Shi-Ying Gao; Chih-Chuan Lin
Journal:  Toxins (Basel)       Date:  2021-03-02       Impact factor: 4.546

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.